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Summary: The p75NTR neurotrophin receptor has been
implicated in multiple biological and pathological proc-
esses. While signiﬁcant advances have recently been
made in understanding the physiologic role of p75NTR,
many details and aspects remain to be determined.
This is in part because the two existing knockout
mouse models (Exons 3 or 4 deleted, respectively), both
display features that defy deﬁnitive conclusions. Here
we describe the generation of mice that carry a condi-
tional p75NTR (p75NTR-FX) allele made by ﬂanking Exons
4–6, which encode the transmembrane and all cytoplas-
mic domains, by loxP sites. To validate this novel condi-
tional allele, both neural crest-speciﬁc p75NTR/Wnt1-
Cre mutants and conventional p75NTR null mutants were
generated. Both mutants displayed abnormal hind limb
reﬂexes, implying that loss of p75NTR in neural crest-
derived cells causes a peripheral neuropathy similar to
that seen in conventional p75NTR mutants. This novel
conditional p75NTR allele will offer new opportunities to
investigate the role of p75NTR in speciﬁc tissues and cells.
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The p75 neurotrophin receptor (p75NTR) is a transmem-
brane protein composed of an extracellular domain con-
taining several cysteine-rich motifs, a transmembrane
domain, and a non-catalytic intra-cellular domain
(Underwood and Coulson, 2008). It can interact with
multiple different ligands and co-receptors and has
been implicated in the regulation of a myriad cellular
process including survival, neurite outgrowth and mye-
linization (Roux and Barker, 2002). p75NTR can bind all
four neurotrophins and can also enhance signal trans-
duction by Trk tyrosine kinase receptors in response to
neurotrophins via a mechanism that is not fully under-
stood (Underwood and Coulson, 2008). Moreover,
p75NTR can form a molecular complex with the Nogo
receptor and transduce myelin inhibitory signals, and
associate with ephrin-A receptors and communicate
reverse EphA signaling (Barker, 2004; Lim et al., 2008).
Some of the functions of p75NTR likely involve the pro-
teolytic cleavage of its extracellular domain by metallo-
proteases followed by cleavage of the transmembrane
domain by g-secretase (Bronfman, 2007). This results in
the production of an intracellular fragment that translo-
cates to the nucleus and participates in transcriptional
events.
To address the role of p75NTR in vivo, Lee et al. gener-
ated a knockout mouse by deleting Exon 3, which enco-
des part of the extracellular domain (Lee et al., 1992).
Homozygote mice are viable and fertile, and do not
show any obvious external phenotypes. However, they
display several defects in the nervous system, such
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FIG. 1. p75NTR targeting vector and screening of ES colonies. (a) A schematic presentation of p75NTR protein domains; the p75NTR
genomic locus depicting a segment from Exon 3 to Intron 6; the p75NTR targeting vector and the p75NTR targeted allele. (b) An example of a
PCR screen using primers a0 and b0 (red arrows) to identify correctly targeted ES cell clones; positive clones: #15, #18, #53, #87, and #132;
‘‘1’’ and ‘‘2’’ depict the positive and negative controls, respectively [(a0) 5 50-GGGGATCCGCTGTAAGTCTGCA-30 and (b0) 50-
TGGGGGAGGGGTGGCTAATTT-3)0. (c) PCR analysis using a/b primers (blue arrows in a; (a) 50-CCTCCGCCAGCTGTCTGCTTCCT-30 and a
reverse primer (b) 50-GGGTGGAAGCTGGGACTGTGCACATGC-30) and template DNA from the putative correctly targeted clones (b) demon-
strate that the clones #15 and #53 had retained the 50 loxP site. The wild type allele produces a 574-bp ampliﬁcation product. Since the
strategy to insert the 50 loxP sites into Intron 3 involved the generation of a 207-bp deletion, the mutant allele gives rise to a 407-bp ampliﬁ-
cation product. (d) Veriﬁcation of the correct targeting using Southern blot analysis. Genomic ES cell DNAs were digested with BamHI and
EcoRI and probed with the external probe (red bar in a). Correctly targeted clones #15 and #53 display both the wild-type and targeted al-
leles of 7.4 and 5.9 kb, respectively, while the non-targeted clones #18 and #87 show only the wild-type allele (7.4 kb). [Color ﬁgure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
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as impaired innervation by peripheral sensory
neurons and decreased sensitivity to NGF (Lee et al.,
1994a,b). Subsequently, von Schack et al. showed that
p75NTRDExon3 encodes an alternatively spliced isoform,
which is apparently present both in wildtype and in
homozygote p75NTRDExon3 mice (von Schack et al.,
2001). Reasoning that this isoform was able to support
some signaling activity, these investigators generated
another p75 mouse line that lacks sequences encoded
by Exon 4 (p75NTRDExon4) (von Schack et al., 2001). The
p75NTRDExon4 mice display more severe defects than
p75NTRDExon3 mutants: about 40% of them die during
the late fetal or early postnatal period, and showed
defects in the descending aorta. The surviving mice are
growth-retarded during the ﬁrst weeks of life, and have
abnormal reﬂexes and impaired motility caused by hind
limb ataxia. It was later shown that the p75NTRDExon4
mutants express an intracellular fragment of p75NTR
that has pro-apoptotic properties (Paul et al., 2004). In
summary, two different mutant mouse strains deﬁcient
in p75NTR have been developed which illuminated new
functions of the receptor in vivo (Lee et al., 1992; von
Schack et al., 2001). Unfortunately, interpretation of the
phenotypes of these mutant strains is complicated by
FIG. 2. Generation of mice carrying the ﬂoxed (p75NTR-FX) and knockout (p75NTR-KO) p75 alleles. (a) Transgenic EIIa-Cremice were crossed
with mice homozygous for the p75 targeting vector. The resulting mosaic males were further crossed with wild-type females to obtain
p75NTR-FX/WT mice (Type I recombination; green arrows c and d depict the primers used [ (c) 50-TGCAGAAATCATCGACCCTTCCC-30 and (d)
50-TCCTCACCCCGTTCTTTCCCC-30]; upper panel) and p75NTR-KO/WT mice (Type II recombination; blue and green arrows depict the
forward and reverse primers, respectively; upper panel). Tail DNAs were analyzed using PCR to identify samples carrying the ﬂoxed allele
(lower left panel; primers shown with blue arrows in the upper panel) or the knockout allele (lower right panel; primers shown with blue
(forward) and green (reverse) arrows in the upper panel). WT, wild type; HE, heterozygote; HO homozygote. (b) RT-PCR analysis of RNAs
isolated from brain (B) or liver (L) tissues of 8-week-old control and p75 knockout mice demonstrates that p75 knockout tissues did not con-
tain any detectable p75 mRNA (upper panel), while control samples showed the expected 210-bp ampliﬁcation product. b-actin-speciﬁc
primers produced a 245-bp ampliﬁcation product of comparable intensity in all samples (bottom panel). (c) Western blot analysis of protein
lysates shows that p75NTR protein is present in wild-type (Wt) brain and liver tissues, while knockout (KO) tissues do not display any detecta-
ble protein (arrow points to the p75NTR protein band). [Color ﬁgure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
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novel and unanticipated molecular signals. Thus, addi-
tional mutant mouse strains are required to clarify the
debate about the various functions of p75NTR.
We generated such a novel mouse line carrying a con-
ditional knockout allele for p75NTR (p75NTR-FX/FX) to
investigate its functions in speciﬁc cells and tissues
in vivo. The allele was designed such that a complete
and conditional knockout can be achieved without the
molecular complexities observed in mice with either
the p75NTRDExon3 (von Schack et al., 2001) or the
p75NTRDExon4 allele (Paul et al., 2004). Our strategy was
to ﬂank Exons 4–6, which encodes the transmembrane
and cytoplasmic domains, by loxP sites. The short (1.6
kb) and long (8.6 kb) arms of the targeting vector were
PCR ampliﬁed from a Bac genomic DNA. A single loxP
site was inserted into Intron 3 and the loxPNeoloxP cas-
sette was inserted into the 30 sequence following the
last Exon 6 (see Fig. 1). As a negative selection marker
we used the diphteria toxin (DT) gene. The linearized
targeting vector was electroporated into TVB2 embry-
onic stem cells as described (Yang and Kaartinen,
2007). Five out of 150 G418-resistant colonies showed
locus-speciﬁc integration (Fig. 1b). Subsequent PCR and
Southern assays conﬁrmed that 2 of them contained the
distant 50 loxP site (Fig. 1c,d). Both correctly targeted
ES clones were able to produce highly chimeric male
mice, which were potent germline transmitters. To
remove the Neo selection marker and to generate a pre-
sumed knockout allele for p75NTR, we crossed the
p75NTR-FXNeo/FXNeo mice (homozygotes for the targeting
vector) with EIIa-Cre transgenic mice (Holzenberger
et al., 2000; Xu et al., 2001). The obtained mosaic male
progeny were subsequently crossed with wild-type
female mice to obtain ﬂoxed (p75NTR-FX) and null
(p75NTR-KO) allele-carrying mouse lines (Fig. 2a). Homo-
zygote p75NTR-FX/FX mice were viable and fertile, and
did not display any overt phenotypes.
To conﬁrm that the p75NTR-KO allele encoded a true
null allele and to provide initial information about
the biological role of p75NTR, we inter-crossed the het-
erozygote p75NTR-KO/WT mice to obtain homozygote
p75NTR-KO/KO mice. Genotype analyses of newborn off-
spring showed the expected Mendelian ratio of wild-
type (p75NTR-WT/WT), heterozygotes (p75NTR-KO/WT), and
homozygotes (p75NTR-KO/KO) consistent with viability of
the p75NTR-KO/KO at birth (n 5 63). RT-PCR using pri-
mers with target sequences in Exons 4 and 6 of brain
and liver samples conﬁrmed that the knockout allele
did not produce any detectable ampliﬁcation product,
while the wild-type control showed the expected 210-
bp fragment (Fig. 2b). Immunoblotting using an anti-
body which recognizes the cytoplasmic domain of
p75NTR conﬁrmed the absence of a p75NTR gene
product in p75NTR-KO/KO mice (Fig. 2c). Homozygote
p75NTR-KO/KO mice showed notable growth retardation
during the ﬁrst weeks of life, but subsequently recov-
ered so that by the age of 10 weeks the size difference
between p75NTR mutants and controls was eliminated
(Fig. 3a,b). Starting at about three weeks of age, p75NTR
null mutants displayed signs of neuropathic pheno-
types. When suspended by the tail, they clenched their
hind limbs under their body, while the controls dis-
played the normal behavior of spreading out their hind
limbs and toes (Fig. 5a,b).
Since p75NTR is strongly expressed in migrating
neural crest cells (NCCs), we generated tissue-speciﬁc
p75NTR mutants by crossing p75NTR-FX/FX mice with
transgenic Wnt1-Cre driver mice, which are known to
be able to induce a robust recombination in early migra-
tory NCCs (Chai et al., 2000; Jiang et al., 2000). Tissue-
speciﬁc p75NTR/Wnt1-Cre mutants were born in the
expected Mendelian numbers and did not display sub-
sequent growth retardation as observed in conventional
p75NTR mutants. Lack of p75 protein in the Wnt1
recombination domain was conﬁrmed by p75NTR immu-
nostaining. As shown in Figure 4, p75NTR was speciﬁ-
cally ablated in the dorsal root ganglia (derived from
NCCs), while its expression in the lateral motor column
was unaffected at E10. p75NTR/Wnt1-Cre mutants dis-
played an abnormal hind limb ‘‘clenching’’ phenotype
similar to that seen in conventional p75NTR mutants sug-
gesting that this common neuropathic phenotype was
at least in part due to the impaired function of p75NTR
speciﬁcally in neural crest cells (Fig. 5c,d). Previous
studies have shown that sciatic nerves are abnormal in
both p75NTRDExon3 and p75NTRDExon4 mutants (von
Schack et al., 2001). Concordant with these ﬁndings,
the sciatic nerves in p75NTR-KO/KO mice showed about a
30% reduction in diameter when compared to those of
control littermates (Fig. 5e–g). In addition, there were
far fewer small diameter axon bundles in the mutant
nerves than in control nerves suggesting that p75NTR
FIG. 3. p75NTR-KO/KO mice are smaller than their wild-type litter-
mates. (a) A p75NTR-KO/KO mouse is smaller (right) than its control
littermate (left) at 4 weeks of age. (b) A line graph depicting the size
difference between mutant (red line) and control (blue line) mice
from 3 weeks of age to 12 weeks of age (three mice were used in
each group).
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mutants may suffer from defects in nociceptive sensory
inputs, which are mostly unmyelinated and lightly-my-
elinated small diameter axons (Fig. 5h,i).
Van Schack et al. have reported that the homozygous
p75NTRDExon3 mutants are born with expected Mende-
lian frequency, but about 40% of corresponding
p75NTRDExon4 mutant mice die during the perinatal
period and suffer from pronounced vascular defects
(von Schack et al., 2001). Here we show that deletion
of the transmembrane and the entire cytoplasmic
domain from the p75NTR gene does not lead to late
gestational, perinatal, or neonatal lethality. Neither
could we detect vasodilatation phenotype in the dorsal
aorta comparable to that seen in p75NTRDExon4 mutants
(data not shown). Instead our present studies demon-
strate that at least some of the neurological phenotypes
result from the need for functional p75NTR in the neural
crest cell lineage, while a role for p75NTR in non-neural
crest is implied by retardation in postnatal growth in
systemic but not Wnt1-Cre-driven conditional mutants.
Whether the more severe phenotype in p75NTRDExon4
mutants when compared either to p75NTRDExon3
mutants or to p75NTR/KOKO mutants described in this ar-
ticle results from a production of an aberrant pro-apo-
ptotic peptide as previously suggested (Paul et al.,
2004), from background differences or from other cur-
rently unknown reasons remains to be shown.
The mutant p75NTR/KO allele described here does not
produce a detectable protein product. Therefore, future
studies using this allele will not be hampered by com-
plexities associated with the use of the p75NTRDExon3
allele, which produces an alternatively spliced product
(von Schack et al., 2001), or with the use of the
p75NTRDExon4 allele, which expresses an aberrantly pro-
apoptotic peptide (Paul et al., 2004). Similarly, the
recently described p75NTR conditional allele, in which
Exon 3 was ﬂanked by loxP sites (Lim et al., 2008), can
be expected to produce a similar alternative splicing
variant as described for the corresponding conventional
knockout allele (Lee et al., 1992). However, Cre-medi-
ated recombination of the p75NTR-FX conditional allele
described here leads to a complete inactivation of the
p75NTR gene. Recent studies have shown that expres-
sion levels of p75NTR undergo dynamic changes during
tissue injury and regeneration (Peterson and Bogen-
mann, 2003; Tomita et al., 2007), but the detailed role
of p75NTR in these processes is currently unknown. The
novel mouse line described here opens new opportuni-
ties to address tissue and cell type-speciﬁc roles of
p75NTR in physiologic and pathologic conditions.
METHODS
Generation of Mice Carrying the Floxed and
Knockout p75NTR Alleles
The long arm of the targeting vector containing the
loxP site in Intron 3 was prepared as follows: A short
(about 1.6 kb) SalI-EcoRI 50 fragment and a long (about
7 kb) BamHI-SacII 30fragment were PCR ampliﬁed
using RP23-67E18 Bac as a template. These fragments
were subcloned and a single loxP site was inserted
between the EcoRI and BamHI sites. The large (about
8.7 kb) 50 arm containing a loxP site in Exon 3 was then
isolated as a single SalI-SacII fragment. The short, 30,
arm was ampliﬁed using RP23-67E18 Bac as a template
as a single XhoI-ClaI fragment. High-ﬁdelity Supermix
(Qiagen) polymerase was used for ampliﬁcation, and
the generated arms were sequenced to verify that no
PCR-generated mutations had been introduced. The tar-
geting vector was assembled by ﬁrst subcloning the
PGK-Neo cassette ﬂanked by loxP sites as a KpnI-BglII
fragment into pKODT digested with KpnI-BamHI. Next
the long SalI-SacII fragment (the long arm) containing
the loxP site in Intron 3 was added into loxP-PGK-Neo-
loxP/pKODT and ﬁnally the short arm was added into
the construct as a ClaI-XhoI fragment. The targeting
vector was electroporated into TVB2 mouse ES cells,
and recombinant ES cell clones were selected with
G418 as described (Dudas et al., 2004; Kaartinen et al.,
1995). Mouse chimeras were generated by injecting cor-
rectly targeted ES clones into C57BL/6J mouse blasto-
cysts. The ﬂoxed p75NTR allele (p75NTR-FX) and the
knockout p75NTR allele (p75NTR-KO) were generated by
crossing female mice homozygous for the targeting vec-
FIG. 4. p75NTR protein is efﬁciently ablated from the dorsal root
ganglia in p75NTR/Wnt1-Cre mutants. (a) In controls p75NTR can be
detected both in the neural crest-derived dorsal root ganglia (DRG)
and in the lateral motor column at E10. (a0) higher power view iden-
tifying the DRG (circled with the white hatched line). (b) In p75NTR/
Wnt1-Cre mutants, p75NTR is present in the lateral motor column,
but not in the DRG. (b0) shows the high power image of the region
indicated in b. An area circled with the hatched line indicates the
DRG region that does not stain positively for p75NTR protein.
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tor with EIIa-Cre transgenic male mice (Xu et al.,
2001). Both EIIa-Cre and Wnt1-Cre mice were from
The Jackson Laboratories (Maine).
PCR Screening, Clone Veriﬁcation,
and Genotyping
ES cell DNAs were ﬁrst screened for correct targeting
by PCR using a forward primer (a0) 50-GGGGATCCG
CTGTAAGTCTGCA-30 and a reverse primer (b0) 50-
TGGGGGAGGGGTGGCTAATTT-30. Subsequently, pres-
ence of the single loxP site in Intron 4 was veriﬁed by
PCR using a forward primer (a) 50-CCTCCGCCAGCT
GTCTGCTTCCT-30 and a reverse primer (b) 50-GGGTGG
AAGCTGGGACTGTGCACATGC-30. p75NTR-FX mice were
genotyped using forward and reverse primers (c) 50-
TGCAGAAATCATCGACCCTTCCC-30 and (d) 50-TCCTCA
CCCCGTTCTTTCCCC-30, respectively, while p75NTR-KO
mice were genotyped using forward (a) and reverse
primers (d). Southern blot analyses of genomic DNAs
digesting with BamHI and EcoRI were used to conﬁrm
homologous recombination using an external probe,
which recognizes sequences encoded by Exon 3 (see
Fig. 1).
Timed Matings and Embryo Generation
Mice were maintained on a daily twelve hour light
cycle and female mice checked for vaginal plugs twice a
day. The day on which a female mouse acquired a vagi-
nal plug was designated as day (‘‘E’’) 0. For the required
embryonic stages, pregnant females were euthanized by
CO2 after the appropriate number of days and embryos
were recovered for analysis. All studies and procedures
performed on mice were carried out at the Animal Care
Facility of the School of Dentistry (ULAM), University of
Michigan-Ann Arbor, and were approved by the Univer-
sity of Michigan Animal Care and Use Committee
FIG. 5. Neurological defects in p75NTR mutants. When suspended by the tail, both p75NTR-KO/KO (b) and p75NTR/Wnt1-Cre (d) mutants dis-
play an abnormal hind limb ‘‘clenching’’ response, while corresponding controls (a and c) show a normal ‘‘stretching’’ response. Sciatic
nerves of adult (1- to 3-months old) p75NTR mutants (f) show about a 30% reduction in diameter when compared to those of control litter-
mates (e). (g) Bar chart showing quantitation of the difference in axon diameter between controls and p75NTR mutants. (i) p75NTR mutant sci-
atic nerves display a statistically signiﬁcant lower number of small diameter unmyelinated and lightly-myelinated axons when compared to
those of controls (h).
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(UCUCA). The mice were maintained in mixed genetic
backgrounds.
RT-PCR
Total RNA was isolated from E8 embryos (RNeasy
mini kit, Qiagen), and cDNAs synthesized (Omniscript
reverse transcription kit, Qiagen) according to manufac-
turer’s protocols. cDNAs were analyzed by PCR for
p75NTR expression using the following primer pairs. b-
actin was used as a quality and loading control.
p75NTR-S 50 GGCAGCTCCCAGCCTGTAGTGACC 30
p75NTR-AS 50 CCGCTGTCGCTGTGCAGTTTC 30
b-actin-S 50 GTGGGCCGGTCTAGGCACCAA 30
b-actin-AS 50 CGGTTGCCTTAGGGTTCAGG 30
Western Blotting
Brain and liver tissues were harvested from three
week old control and mutant mice, and lysed in 23
Laemmli sample buffer (Harlow and Lane, 1988). About
10 lg of protein per lane was resolved on NuPAGE BisT-
ris SDS PAGE gels (Invitrogen) using the X-Cell SureLock
Mini-Cell electrophoresis system (Invitrogen) and elec-
troblotted onto PVDF membrane (Invitrogen). The
membrane was blocked and incubated overnight at 48C
with anti-p75NTR antibody (Millipore). The membrane
was then probed with horseradish peroxidase (HRP)-
conjugated goat anti-rabbit antibody and visualized with
ECL reagents (Immobilon Western, Millipore). The
chemiluminescent signal was recorded using the Bio-
Spectrum AC Imaging system (UVP).
Immunohistochemistry
Embryos (E10) were ﬁxed in 4% paraformaldehyde in
phosphate-buffered saline (PBS) at 48C for 1 h, dehy-
drated, cleared in toluene, and embedded in parafﬁn.
Serial 7-lm-thick transverse sections were mounted on
Superfrost Plus slides (Fisher Scientiﬁc). After epitope
recovery by proteinase K digestion (20 lg ml21 for 6
min at room temperature), sections were incubated
with anti-p75NTR rabbit anti-mouse primary antibody
(Advanced Targeting Systems) at 1:200 dilution at 48C
overnight followed by Alexa Fluor 488-conjugated goat
anti-rabbit IgG (Invitrogen) secondary antibody labeling.
Vectashield mounting medium with DAPI for ﬂuores-
cence (Vector Laboratories) was used for mounting
slides and staining nuclei. The results were examined
and recorded on an Olympus BX51 microscope and
photographed using a DP71 camera and DP controller
software (Olympus).
Sciatic Nerve Analysis
Postnatal 1- to 3-month-old control and mutant mice
were perfused with 4% paraformaldehyde and the left
and right sciatic nerves dissected. Semithin plastic
sections were prepared and stained with toluidine blue.
Mosaic images of entire cross sections of sciatic nerve
from comparable anatomic levels were collected using
a microscope with a motorized stage (Axiovert 200M,
Zeiss). The diameter of the sciatic nerves were meas-
ured and compared between mutant and control mice
using the analysis software (Axiovision, Zeiss). The data
are displayed as the mean 6 SEM of four nerves from
each genotype. The data were subjected to a student’s t-
test and a P-value <0.05 was considered signiﬁcant.
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